ArticleMedical oncology (Northwood, London, England)2023

Cancer stemness kinase inhibitor amcasertib: a promising therapeutic agent in ovarian cancer stem and cancer cell models with different genetic profiles.

Hale Guler Kara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.